Kevin Huang MD
Assistant Professor, Gastroenterology
72 East Concord Street | (617) 414-5951huangk@bu.edu
Sections
Gastroenterology
Biography
Kevin Huang is a gastroenterologist at Boston Medical Center, Co-Director of the Center for Digestive Disorders Neurogastroenterology and Motility Program, and Assistant Professor of Medicine at Boston University. His clinical and research interests focus on gastrointestinal motility disorders - including achalasia, esophageal dysmotility, gastroparesis, and dyssynergic defecation - as well as disorders of gut-brain interaction, such as functional dyspepsia, irritable bowel syndrome, and chronic abdominal pain. He also has an interest in GI manifestations of scleroderma.
Education
Medicine, MD, University of North Carolina at Chapel Hill
Biology, BS, Emory University
Publications
Huang Q, Lew E, Cheng Y, Huang K, Deshpande V, Shinagare S, Yuan X, Gold JS, Wiener D, Weber HC. Prognostic factors in clinicopathology of oesophagogastric adenocarcinoma: a single-centre longitudinal study of 347 cases over a 20-year period. Pathology. 2024 Jun; 56(4):484-492. PMID: 38480051.
Published on 2/1/2024Chiu LS, Huang KZ, Xu X, Heeren T, Haque R, Schroy PS. Initial Stage of Disease Similar for White and Black Patients With Early-Onset Colorectal Cancer at a Safety-Net Hospital. J Clin Gastroenterol. 2024 Feb 01; 58(2):162-168. PMID: 36806090.
Published on 8/13/2021Huang KZ, Kumar NL. A High-Yield Approach to Effective Endoscopy Teaching and Assessment. Clin Gastroenterol Hepatol. 2021 10; 19(10):1999-2001. PMID: 34391715.
Published on 12/18/2020Huang KC, Chiang SF, Chen TW, Chen WT, Yang PC, Ke TW, Chao KSC. Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy. Sci Rep. 2020 Dec 18; 10(1):22330. PMID: 33339860.
Published on 11/5/2020DeLay K, Tappata M, Huang KZ, Koutlas NT, Robey BS, Fan C, Eluri S, Menard-Katcher P, Dellon ES. Long-term Continued Proton Pump Inhibitor Use is Common in Patients Diagnosed with Eosinophilic Esophagitis Despite Failure of Histologic Response: Data from a two-centre study: Long-term PPI Use in Patients with EoE. GastroHep. 2020 Nov; 2(6):281-287. PMID: 35356404.
Published on 11/4/2020Huang C, Hopkins R, Huang K, Demers L, Wasan S. Standardizing Endoscopy Training: A Workshop for Endoscopy Educators. MedEdPORTAL. 2020 11 04; 16:11015. PMID: 33204839.
Published on 3/5/2020Eluri S, Tappata M, Huang KZ, Koutlas NT, Robey BS, Fan C, Reed CC, Shaheen NJ, Dellon ES. Distal esophagus is the most commonly involved site for strictures in patients with eosinophilic esophagitis. Dis Esophagus. 2020 Mar 05; 33(2). PMID: 31778150.
Published on 3/14/2019Chen TW, Huang KC, Chiang SF, Chen WT, Ke TW, Chao KSC. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy. J Cancer Res Clin Oncol. 2019 Apr; 145(4):1043-1053. PMID: 30874889.
Published on 3/1/2019Huang KZ, Dellon ES. Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders. J Gastrointestin Liver Dis. 2019 Mar; 28(1):47-51. PMID: 30851172.
Published on 1/1/2019Jensen ET, Huang KZ, Chen HX, Landes LE, McConnell KA, Almond MA, Safta AM, Johnston DT, Durban R, Jobe L, Frost C, Donnelly S, Antonio B, Quiros A, Markowitz JE, Dellon ES. Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):50-55. PMID: 30074576.